Orion Oyj
ORION CORPORATION STOCK EXCHANGE RELEASE 1 MARCH 2021 at 18.45 EET
Orion Corporation: Transfer of 99,768 own B shares on 1 March 2021
In accordance with a decision by the Board of Directors, Orion Corporation has on 1 March 2021 transferred altogether 99,768 Orion Corporation B shares held by the company as a share reward for earning periods 2018–2020 and 2019–2020 to the persons belonging to the Share-based Incentive Plan of the Orion Group. The transfer is based on the authorisation by the Annual General Meeting of 26 March 2019.
The price per share of the transferred shares is EUR 34.1055, which is the volume weighted average quotation of the Orion Corporation B share on 1 March 2021. Accordingly, the total transaction price of the transferred shares is EUR 3,402,637.52.
After the share transfer, the total number of own B shares held by Orion Corporation is 571,314.
Orion Corporation has informed about the Share-based Incentive Plans in stock exchange releases on 2 February 2016 and on 6 February 2019.
Orion Corporation
Timo Lappalainen President and CEO | Olli Huotari SVP, Corporate Functions |
Contact person:
Olli Huotari, SVP, Corporate Functions, tel. +358 10 426 3054, mobile +358 50 966 3054
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's net sales in 2020 amounted to EUR 1,078 million and the company had about 3,300 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Cellebrite DI Ltd14.3.2024 14:01:14 CET | Press release
Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure Platform
TrueCommerce12.3.2024 13:01:14 CET | Pressemeddelelse
TrueCommerce anerkendes igen som en leder i IDC MarketScape: Worldwide Multi-Enterprise Supply Chain Commerce Network
NetBet4.3.2024 10:41:43 CET | Press release
NetBet Casino in Denmark Now Features IGT PlayDigital Content
NetBet4.3.2024 10:41:43 CET | Pressemeddelelse
NetBet Casino i Danmark indeholder nu spil fra IGT PlayDigital
FUJIFILM Europe GmbH29.2.2024 12:37:58 CET | Press release
Fujifilm Healthcare Europe partners with R Zero to bring next-gen training simulation technology to European endoscopists
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom